Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FT491
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $55,990
Award facts
- Contract value 100% obligated
- $55,989.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pen auto-injectors with a ceiling value of $55,989.92 under a firm fixed price contract type. The award, issued on October 31, 2025, with an ultimate completion date of November 3, 2025, represents a non-competitive delivery order with no set-aside designation. This contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime vendor agreement enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare systems globally, including the Defense Health Agency and U.S. Coast Guard. DUPIXENT (dupilumab) is a specialty biologic medication used for treating moderate-to-severe atopic dermatitis, eosinophilic asthma, and related conditions, making this delivery order representative of AmerisourceBergen's ongoing role as a critical vendor for specialized pharmaceutical procurement within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FT491?
SPE2DR26FT491 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DR26FT491 worth?
The government has obligated $55,990 on SPE2DR26FT491.
Is contract SPE2DR26FT491 an order under another contract?
Yes. SPE2DR26FT491 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FT491 competed?
The extent of competition for SPE2DR26FT491 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award